Patient-Led Peer Support Groups Improve Anti-Hypertensive Drugs Access for Adults Living with HIV and Hypertension in Rural Uganda – A Cross-Sectional Study Authors: Mucunguzi Atukunda, Brian Twinamatsiko, Michael Ayebare, Elizabeth Arinitwe, Aida N Kawuma, Ronald Kiguba, Joanita Nangendo, Gerald Mutungi, Fred C Semitala, Moses R Kamya, Jane Kabami Published: 2026 ABSTRACT AbstractIntroductionPeople living with HIV (PLHIV) often have poorly controlled hypertension due to medication non-adherence, primarily caused by limited access to antihypertensive drugs. Peer support groups are being explored to improve access. We evaluated the feasibility and acceptability of peer support groups to improve access to anti-hypertensive drugs for PLHIV with hypertension.MethodsFrom December 2022 to April 2023, we conducted a cross-sectional survey and measurement of blood pressure among PLHIV in 26 health facilities to assess the accessibility of anti-hypertensive drugs in the peer support groups. The collected data was summarized using descriptive statistics.ResultsEight out of 26 health facilities formed peer support groups. Among 163 PLHIV interviewed only 64 participated in the peer support groups. Among those who participated in peer support groups, 57% reported accessing anti-hypertensive drugs through the group. The peer support groups were affordable for most participants. Around 60% found the contributions manageable, with 79% contributing $1.3 or less. Most participants expressed satisfaction in the performance of the peer support groups. And blood pressure control was higher among survey participants in peer support groups (53.1%) compared to those not in such groups (33.3%), with an overall control rate of 41.1%.ConclusionThe results of the study suggest that patient-led peer support groups are a feasible intervention to improve access to antihypertensive medications for PLHIV with Hypertension.Keywords: HIV, hypertension, peer support groups, anti-hypertensive drugs, multi-morbidity Introduction Hypertension among people living with HIV (PLHIV) shows a growing trend globally.1 With the introduction of Anti-retroviral therapy (ART), the life expectancy of PLHIV has substantially improved.2 As a result of ageing, PLHIV are at a higher risk of suffering multi-morbidity including HTN.3 The prevalence of hypertension among PLHIV ranges from 17% to 50% in low- and middle-income countries.4–8 The management of PLHIV with hypertension includes lifestyle modifications and the use of anti-hypertensive medicines.9 The use of anti-hypertensive drugs is the mainstay treatment of uncontrolled Hypertension. However, Hypertension control among PLHIV is sub-optimal10,11 and non-adherence to anti-hypertensive medicine remains the leading cause of sub-optimal Hypertension control among Hypertension patients.12 One of the key drivers of non-adherence is limited access to drugs because of high costs, lack of knowledge among health providers, and clinical inertia. The World Health Organization (WHO) calls for increased access and affordability of all medicines.13 However, access to drugs to prevent and treat non-communicable diseases (NCDs) is unacceptably low in Uganda.14–18 Moreover, most health facilities (84%) reported essential medicine stockouts within the past six months, primarily driven by sudden increases in demand (59%), delivery delays (40%), and order-delivery discrepancies (35%).19 The inadequacy of stocks of medicines for NCDs affects all hypertension patients including PLHIV.20,21 Thus, low- and middle-income countries are encouraged to increase mobilization of domestic resources to cater for the many patients with NCDs with limited access to anti-hypertensives.22 Even then, national government mobilization is limited, and the burden of access to anti-hypertensive medicines is largely left to patients to make out-of-pocket payments. Peer support groups have been instrumental in providing support to patients with chronic illnesses.23 Peer-to-peer engagements create opportunities for support in areas such as adherence, counselling, patient education and patient advocacy.24 In the case of Uganda, the Ministry of Health (MoH) supports the formation of patient associations to tackle the issue of drug stockouts. In that regard, MoH issued guidance to healthcare managers allowing the formation of peer support groups. The peer support groups ask members to make voluntary financial contributions to purchase anti-hypertensive drugs in bulk at a low cost. This ensures that all patients in the support group access anti-hypertensive medicines during routine clinic visits to the health facility. Despite the potential benefits of peer support groups, they have not yet been studied in the context of PLHIV who also have hypertension. HIV-related clinical activities offered at the health facilities included HIV testing counselling and management of ART. Provision of HIV services at these health facilities is made by, medical doctors, clinical officers, nurses, HIV counsellors, laboratory technicians, pharmacy technicians, and record officers, supported by HIV expert clients. HTN care and treatment services are routinely offered at all these health facilities. If a PLHIV has Hypertension, the clinician prescribes both ART and Hypertension medicines and gives the individual a future appointment for clinical evaluation and monitoring. All available drugs and services at the health facility are provided at no cost to the patients. However, during drug stock-out periods, patients are advised to purchase medicines at private pharmacies of their preference. The work detailed in this manuscript was performed alongside that of the Integrated HIV/HTN project a cluster randomized trial (https://classic.clinicaltrials.gov/ct2/show/NCT04624061). As part of the Integrated HIV/HTN project implementation, project staff recommended establishing peer support groups at health facilities, aligning with Ministry of Health guidance. The Integrated HIV/HTN project aimed to measure the effectiveness of integration on HTN screening, blood pressure control and dual HIV and HTN control among PLHIV. The objective of this study was to evaluate the feasibility and acceptability of patient-led peer support groups designed to improve anti-hypertensive drug stockouts for PLHIV with HTN within the Integrated HIV/HTN project. Methods Study Design We conducted a cross-sectional survey using a structured questionnaire to a randomly selected PLHIV with HTN attending peer support groups and PLHIV with HTN not attending peer support groups from 1 December 2022 to 28 April 2023. Study Setting and Population The study was conducted at intervention health facilities under the Integrated HIV/HTN project in South-western Uganda. There were 26 government-supported health facilities under the intervention providing comprehensive HIV services with the number of PLHIV at the health facility ranging from 200 to 1,000 persons. The intervention package components included (1) Training and capacity building on the Integrated HIV/HTN model and NCD care. (2) The Integrated HIV/HTN care delivery model by promoting HTN screening and care in HIV clinics. (3) HMIS enhancements through mentorship and coaching on the use of NCD registers and patient cards, and capture of HTN data in the existing Electronic Medical Records (EMR) of Uganda; and (4) SMS and/or WhatsApp messages for data coordination and communication among providers, District Health Officers, and project staff. The integrated HIV/HTN protocol has been published.25 Formation of Peer Support Groups The concept of peer support groups was introduced to the study facilities by the Integrated HIV/HTN project team during a performance review meeting attended by superintendents of all the participating health facilities in April 2021. This followed reports from healthcare providers indicating that many health facilities experienced frequent stockouts of anti-hypertensive medicines due to intermittent government supplies. Consequently, several PLHIV and Hypertension spent months without anti-hypertensive medicines. To improve the availability of drugs for non-communicable diseases, the Uganda Ministry of Health had recommended formation of peer support groups. The peer support groups would work by asking members of the support group to collectively raise funds to buy drugs in bulk at a cheaper price. The peer support groups would select an executive committee among the members to support different tasks. The executive committee comprised at least a chairperson, a secretary, and a treasurer. The treasurer was charged with receiving and keeping the members’ financial contributions. Following that consultative performance review meeting in the Integrated HIV/HTN project, healthcare providers mobilized and encouraged several patients to form patient-led peer support groups attached to their health facilities. The health facilities that formed patient-led peer support groups include Ndeija Health center (HC) III, Ntugamo HC IV, Kibaale HC IV, Mugarama HC III, Rwekubo HC IV, Kakoba HC III and Mwizi HC III. We also included Ruhoko HC IV which was not part of the integrated HIV/HTN project but had an active peer support group. A Level IV health facility is overseen by a Medical Doctor and serves a population of 100,000 to 500,000 within its catchment area. These facilities are equipped to handle a wider range of medical needs, including inpatient care with a 30-bed capacity, surgical procedures in an operating theatre, diagnostic testing in a general laboratory, and ongoing management of HIV with a dedicated chronic care unit. In contrast, Level III Health facilities are led by a qualified clinician, nurse, or midwife. They cater to a population of up to 30,000 within their designated area and focus on primary care services. These facilities typically include outpatient departments, maternity wards, and HIV chronic care units. It’s important to clarify that peer support groups were not originally included in the integrated HIV/HTN project interventions. However, the project team encouraged health facilities to establish these groups as a complementary strategy to help patients access and adhere to their hypertension medication. Each peer support group typically comprised 5–15 PLHIV who also had hypertension, alongside 10–30 non-HIV individuals with HTN. These groups functioned under a patient-led model, meaning patients managed and facilitated the group discussions and activities. However, the health providers gave oversight and technical support whenever needed. Healthcare providers offered technical support to the peer support groups by recommending appropriate antihypertensive medications and, in some cases, suggesting reliable sources for purchasing these medications. Participation in the peer support groups was entirely voluntary, with patients free to join or leave at any time. For cost estimates, the exchange rate was around 3846 Ugandan shillings (UGX) to 1 US dollar in 2022. We purposively included all health facilities that had patient-led support groups. Data Collection Procedures We collected data on basic demographics, and blood pressure (BP) measurements during the survey. The data collection tool underwent expert review to ensure content validity and reliability prior to administration. This level of validation was deemed appropriate for this study, as the tool was designed to capture descriptive data regarding patient-led support groups. Blood Pressure measurement was conducted using sphygmomanometers (Omron M2 IntellisenseTM Automatic Blood Pressure Monitor, Lake Forest, IL. USA) after an initial period of a seated 5-minute rest. When the first BP measurement reading was normal (<140/<90 mmHg), no additional BP readings were taken. However, when the first reading was 140/90 mmHg or higher, two additional readings were performed at alternate patient arms three minutes apart, the average BP reading among the three readings would be recorded as final. Study Outcomes The primary outcome was the accessibility of anti-hypertensive drugs through the peer support groups, measured as the number of PLHIV with HTN accessing anti-hypertensives through the peer support groups. Secondary outcomes were participant participation rates in the support groups, measured as the number of PLHIV with HTN willing to join patient clubs and acceptability measured as the number of PLHIV with HTN willing to pool funds in the peer support group to buy drugs. Data Analysis Baseline information was collected and summarized using descriptive statistics. Blood Pressure findings were categorized using the 2020 guidelines of the American Society of Hypertension and the International Society of Hypertension: Normal: <140/90 mmHg; Grade-1 HTN: 140–159/90-99 mmHg; Grade-2 HTN: 160–179/100–109 mmHg; Grade-3 HTN: ≥180/110.26 Results From 3 December 2022 to 20 April 2023, eight out of twenty-six (30.7%) health facilities had established peer support groups for diabetes and hypertension. Health facilities were evenly distributed, with four health facilities at level IV (Ntungamo HC IV, Kibaale HC IV, Ruhoko HC IV and Rwekubo HC IV) and four health facilities at level III (Ndeija HC III, Mugarama HC III, Kakoba HC III and Mwizi HC III). Out of the 163 PLHIV participants interviewed, 39.3% (64 participants) were members of peer support groups. More than two-thirds (107) of the PLHIV participants received care at Level IV health facilities. There were more PLHIV 58/63 (90.5%) enrolled at Level IV health facilities than at Level III facilities with just 6/63 (9.5%). There was no variation in the number of PLHIV not participating in HTN peer support groups by level of health facility (50.5%) at level III vs 49.5% at Level IV. Slightly over half of the participants 55.2% (90/163) were females, with variation by membership status; 38 (60.3%) were in the HTN peer support group and 52 (52.5%) were not in a peer support group. The mean age for participants was 51.7 years and did not differ by HTN peer support group participation status. Over half of the participants, 97/163 (59.5%) had attained a primary level of education and this did not differ by peer support group participation status; with 38 (23.3%) reporting to have never attended school at all. Most of the PLHIV (99.4%) were on pharmacological HTN treatment, with one participant on the non-pharmacological HTN treatment. Duration of treatment among the participants varied with more than half of the participants having been on treatment for over 6 months. Overall, 41.1% (67/163) had controlled blood pressure at the time survey and it varied significantly by peer support group participation; with 53.1% (34/64) participants in the peer support group and 33.3% (33/99) participants not in the peer support groups. Nearly all participants (97.5%) had been on ART treatment for more than a year (Table 1). Table 1Sociodemographic and Clinical Characteristics in N (%), Unless Noted, of Persons Living with HIV with Hypertension Who Participated in the Cross-Sectional Survey Conducted in Southwestern Uganda from December 2022 to April 2023CharacteristicsPeer Support GroupNot in Peer Support GroupTotalN=64N=99N=163Health Facility Level III6 (9.5%)50 (50.5%)56 (34.4%) Level IV58 (90.5%)49 (49.5%)107 (65.6%)Female, Sex38 (59.4%)52 (52.5%)90 (55.2%)Age, Mean [SD]52.6 (10.1%)51.1 (12.4%)51.7 (11.6%)Education No school112738 (23.3%) Primary425597 (59.5%) Secondary6814 (8.6%) Tertiary/Vocational5510 (6.1%) University033 (1.8%) Post-graduate011 (0.6%)ART Treatment duration 1–3 months011 (0.6%) 4–6 months011 (0.6%) 6–12 months112 (1.2%)More than a year ago6396159 (97.5%)Hypertension Treatment Pharmacological6498162 (99.4%) Non-pharmacological011 (0.6%)Hypertension treatment duration Less than a month123 (1.8%) 1–3 months91625 (15.3%) 4–6 months101525 (15.3%) 6–12 months92433 (20.2%)More than a year ago354277 (47.2%)Blood pressure control34 (53.1%)33 (33.3%)67 (41.1%) Sociodemographic and Clinical Characteristics in N (%), Unless Noted, of Persons Living with HIV with Hypertension Who Participated in the Cross-Sectional Survey Conducted in Southwestern Uganda from December 2022 to April 2023 Participation of PLHIV in the Peer Support Groups The duration for participation in the HTN peer support varied by months as follows: 6/63 (9.5%) for <1 month, 25/63 (40%) for 1–3 months, 21/63 (33%) for 4–6 months, 5/63 (7.9%) for 6–12 months and 6/63 (9.5%) for over 12 months. Among those who participated in peer support groups, 57% (36/63) reported accessing anti-hypertensive drugs through the group. Less than half (44.4%) of participants did not spend on buying HTN medication before joining the peer support group. Whereas one individual (1.5%) spent between UGX10,000–30,000 (USD 2.6–7.8), 22/63 (34.9%) spent between UGX5,000–10,000 (USD 1.3–2.6), and 12/63 (19%) spent less than UGX. 5,000 (USD 1.3) averagely per month on buying HTN medications before joining the peer support group. The amount of money contributed by each PLHIV to the peer support group varied greatly among participants, with 21/63 (33%) contributing UGX. 3,000 (USD 0.8), 29/63 (46%) UGX. 5,000 (USD 1.3), 2/63 (3.2) UGX. 7,000 (USD 1.8), 8/63 (13%) UGX. 10,000 (USD 2.6) and three individuals (1.6%) each contributing UGX. 20,000 (USD 5.2) and above. More than half 38/63 (60.3%) reported the financial contributions made to the peer support group were affordable. Member contributions to the peer support groups were made either once in three months (52%) or monthly (48%). Activities carried out in the HTN peer support groups (n = 61) included health education, peer counselling, blood pressure measurement, and group financial savings. Health education was the most commonly reported activity (56%, n = 34), followed by health education combined with peer counselling (30%, n = 18). Other activities included health education with blood pressure measurement (6.6%, n = 4), health education with both blood pressure measurement and peer counselling (4.9%, n = 3), and health education with group financial savings (3.3%, n = 2) (Table 2). Table 2Number and Proportion of Persons Living with HIV Who Attended Peer Support Groups and Participated in the Cross-Sectional Survey Conducted in Southwestern Uganda from December 2022 to April 2023Category Duration of participation in the peer support groupN=63%<1 month69.51–3 month25404–6 month21336–12 month57.9>12 months69.5The average amount spent monthly buying HTN medications before joining peer support groupN=63%< $1.3 (